These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 973611)

  • 1. Evaluation of Wistar RA27/3 rubella virus vaccine in children.
    Balfour HH; Balfour CL; Edelman CK; Rierson PA
    Am J Dis Child; 1976 Oct; 130(10):1089-91. PubMed ID: 973611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RA27/3 rubella vaccine. A four-year follow-up.
    Balfour HH; Groth KE; Edelman CK
    Am J Dis Child; 1980 Apr; 134(4):350-3. PubMed ID: 7369197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rubella in Orkney: seroepidemiology and vaccination.
    Moffat MA; Heywood SN; Laughton E; Gould JJ; Freestone DS
    J Hyg (Lond); 1977 Jun; 78(3):419-27. PubMed ID: 266542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the reactogenicity and immunogenicity of the BRD-2 and RA27/3 live attenuated rubella vaccines.
    Wang SS; Han YR; Su WN; Chen J; Zhao K
    Vaccine; 1984 Dec; 2(4):277-80. PubMed ID: 6531968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic response to revaccination with two rubella vaccines.
    Brandling-Bennett AD; Jackson RS; Halstead SB; Campbell CC; Herrmann KL; Modlin JF; Meyers JD; Witte JJ
    Am J Dis Child; 1976 Oct; 130(10):1081-4. PubMed ID: 973610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody titres in women six to eight years after the administration of RA2713 and Cendehill rubella vaccines.
    Macdonald H; Tobin JO; Cradock-Watson JE; Lomax J
    J Hyg (Lond); 1978 Jun; 80(3):337-47. PubMed ID: 649946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of vaccine-induced immune responses to rubella: comparison with natural infection.
    Horstmann DM; Schluederberg A; Emmons JE; Evans BK; Randolph MF; Andiman WA
    Rev Infect Dis; 1985; 7 Suppl 1():S80-5. PubMed ID: 4001740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States.
    Plotkin SA; Farquhar JD; Ogra PL
    JAMA; 1973 Aug; 225(6):585-90. PubMed ID: 4740523
    [No Abstract]   [Full Text] [Related]  

  • 9. Further evaluation of the optimum age for rubella vaccine administration.
    Wilkins J; Wehrle PF
    Am J Dis Child; 1979 Dec; 133(12):1237-9. PubMed ID: 517472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rubella prevention in family practice with RA27/3 vaccine.
    Hansen NH
    J Fam Pract; 1980 Oct; 11(4):537-42. PubMed ID: 7420029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific immunoglobulin responses in serum and nasal secretions after the administration of attenuated rubella vaccine.
    Cradock-Watson JE; Macdonald H; Ridehalgh MK; Bourne MS; Vandervelde EM
    J Hyg (Lond); 1974 Aug; 73(1):127-41. PubMed ID: 4608331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phases 3 and 4 immunization immunogenicity with combined measles-rubella vaccine].
    Ozaki T; Nishimura N; Gotoh K; Ohe K; Funahashi K; Maeda K; Okuno Y
    Kansenshogaku Zasshi; 2011 May; 85(3):250-5. PubMed ID: 21706844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological response to rubella revaccination.
    Serdula MK; Halstead SB; Wiebenga NH; Herrmann KL
    JAMA; 1984 Apr; 251(15):1974-7. PubMed ID: 6700099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-three-year follow-up study of rubella antibodies after immunization in a closed population, and serological response to revaccination.
    Asahi T; Ueda K; Hidaka Y; Miyazaki C; Tanaka Y; Nishima S
    Vaccine; 1997 Nov; 15(16):1791-5. PubMed ID: 9364685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rubella susceptibility in sixth graders: effectiveness of current immunization practice.
    Lawless MR; Abramson JS; Harlan JE; Kelsey DS
    Pediatrics; 1980 Jun; 65(6):1086-9. PubMed ID: 7375231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rubella immunity measured by hemagglutination inhibition and enzyme-linked immunosorbent assay.
    Hornstein L; Swartz TA; Heimann M
    Isr J Med Sci; 1985 Aug; 21(8):666-9. PubMed ID: 4044233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durability of antibody titers induced by RA27/3 rubella virus vaccine.
    Black FL; Lamm SH; Emmons JE; Pinheiro FP
    J Infect Dis; 1978 Mar; 137(3):322-3. PubMed ID: 632628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and immunization of rubella-susceptible women. Experience in a large, prepaid medical group.
    Shlian DM
    JAMA; 1978 Aug; 240(7):662-3. PubMed ID: 671687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rubella viraemia and antibody responses after rubella vaccination and reimmunization.
    Balfour HH; Groth KE; Edelman CK; Amren DP; Best JM; Banatvala JE
    Lancet; 1981 May; 1(8229):1078-80. PubMed ID: 6112449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity to intranasal challenge with Rubella virus two years after vaccination: comparison of three vaccines.
    Grillner L
    J Infect Dis; 1976 Jun; 133(6):637-41. PubMed ID: 932491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.